Chapman, SR, Fitzapatrick, R and Aladul, M (2019) Differences in UK healthcare professionals" knowledge,,attitude and practice towards infliximab and insulin glargine biosimilars. International Journal of Pharmacy Practice, 27 (2). pp. 214-217. ISSN 2042-7174

[thumbnail of Aladul_et_al-2018-International_Journal_of_Pharmacy_Practice.pdf]
Aladul_et_al-2018-International_Journal_of_Pharmacy_Practice.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (298kB) | Preview


To investigate knowledge and attitudes of different healthcare professionals in UK towards infliximab and insulin glargine biosimilars.

UK medical consultants/registrars, nurses and pharmacists participated in anonymised, self‐administered web‐based survey distributed by professional associations.

Key findings
There were 234 respondents: medical consultants/registrars (150), nurses (58) and pharmacists (26). 76% of medical consultants/registrars, 84% of pharmacists and 53% of nurses understood what biosimilars were. Medical consultants/registrars and pharmacists had safety and efficacy concerns when switching patients compared to initiation. Nurses had similar levels of safety and efficacy concerns about initiation.

Healthcare professionals were more comfortable with the initiation of biosimilars than switching current patients. Medical consultants/registrars and pharmacists were more informed than nurses.

Item Type: Article
Additional Information: This is the final published version of the article (version of record). It first appeared online via Wiley at - Please refer to any applicable terms of use of the publisher.
Uncontrolled Keywords: biosimilar, medical consultants, nurse, pharmacist
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Medicine and Health Sciences > School of Pharmacy
Depositing User: Symplectic
Date Deposited: 03 Sep 2018 08:14
Last Modified: 26 Mar 2021 09:31

Actions (login required)

View Item
View Item